Waycross Partners’s DexCom DXCM Stock Holding History

Waycross Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$1.33M	–	91
2025 Q4	$1.33M	Hold	20,000	–	–	0.11%	53
2025 Q3	$1.35M	Hold	20,000	–	–	0.12%	53
2025 Q2	$1.75M	Hold	20,000	–	–	0.16%	49
2025 Q1	$1.37M	Hold	20,000	–	–	0.15%	47
2024 Q4	$1.56M	Hold	20,000	–	–	0.2%	46
2024 Q3	$1.34M	Hold	20,000	–	–	0.19%	48
2024 Q2	$2.27M	Hold	20,000	–	–	0.35%	42
2024 Q1	$2.77M	Hold	20,000	–	–	0.48%	36
2023 Q4	$2.48M	Sell	20,000 -7,850	-28%	-$802K	0.47%	40
2023 Q3	$2.6M	Hold	27,850	–	–	0.57%	35
2023 Q2	$3.58M	Buy	27,850 +7,450	+37%	+$901K	0.78%	33
2023 Q1	$2.37M	Buy	20,400 +5,000	+32%	+$560K	0.69%	39
2022 Q4	$1.74M	Hold	15,400	–	–	0.63%	40
2022 Q3	$1.24M	Buy	15,400 +11,000	+250%	+$932K	0.83%	41
2022 Q2	$328K	Hold	4,400	–	–	0.22%	75
2022 Q1	$563K	Hold	4,400	–	–	0.33%	68
2021 Q4	$591K	Hold	4,400	–	–	0.34%	70
2021 Q3	$602K	Hold	4,400	–	–	0.38%	66
2021 Q2	$470K	Hold	4,400	–	–	0.25%	69
2021 Q1	$395K	Buy	+4,400	New	+$413K	0.22%	77

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Waycross Partners's DXCM Position: Q1 2026 in Review

Waycross Partners sold out of DexCom (DXCM) in Q1 2026, closing a stake of 20,000 shares — an estimated $1.33M sold.

Waycross Partners first reported a position in DXCM in Q1 2021 and held it in 20 quarters. The position peaked at $3.58M in Q2 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Waycross Partners reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Waycross Partners sold 20,000 DexCom shares in Q1 2026, an estimated $1.33M.
Waycross Partners first reported a position in DexCom in Q1 2021 and held it in 20 quarters.
Waycross Partners's DexCom position peaked at $3.58M in Q2 2023.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Waycross Partners's 13F filing for Q1 2026, filed 7 May 2026.